Net Cash Provided by (Used in) Operating Activities |
-13.1M |
USD |
-1245% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-54.7M |
USD |
-4179% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
62.1M |
USD |
|
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
1B |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
13.6M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-5.72M |
USD |
-583% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
16.7M |
USD |
-40.2% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
4.35M |
USD |
+50.2% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
26.9M |
USD |
+25.1% |
Q2 2025 |
Q2 2025 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q1 2025 |
Q1 2025 |
Deferred Income Tax Expense (Benefit) |
2.3M |
USD |
|
Q4 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Current Income Tax Expense (Benefit) |
156K |
USD |
-7.14% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
306M |
USD |
0% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Depreciation, Depletion and Amortization |
1.86M |
USD |
-53.9% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
-100% |
Q2 2025 |
Q2 2025 |
Share-based Payment Arrangement, Expense |
0 |
USD |
|
Q2 2025 |
Q2 2025 |
Interest Expense |
18.7M |
USD |
+15.8% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |